Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions.… Read more
Guangdong VTR Bio-Tech Co Ltd (300381) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.021x
Based on the latest financial reports, Guangdong VTR Bio-Tech Co Ltd (300381) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.41 Million) by net assets (CN¥2.64 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangdong VTR Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Guangdong VTR Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guangdong VTR Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong VTR Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shaanxi Jinye Science Technology and Education Group Co Ltd
SHE:000812
|
0.148x |
|
Shanghai Laimu Electronics Co Ltd
SHG:603633
|
-0.006x |
|
Promate Electronic Co Ltd
TW:6189
|
-0.024x |
|
PT Golden Energy Mines Tbk
JK:GEMS
|
0.066x |
|
Dave & Buster’s Entertainment
NASDAQ:PLAY
|
0.443x |
|
Flagship Communities Real Estate Investment Trust
PINK:MHCUF
|
0.026x |
|
Shenzhen Rayitek Hi-Tech Film Co. Ltd. A
SHG:688323
|
0.019x |
|
Sirio Pharma
SHE:300791
|
0.038x |
Annual Cash Flow Conversion Efficiency for Guangdong VTR Bio-Tech Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong VTR Bio-Tech Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.65 Billion | CN¥69.19 Million | 0.026x | -53.82% |
| 2023-12-31 | CN¥2.74 Billion | CN¥154.40 Million | 0.056x | -36.36% |
| 2022-12-31 | CN¥2.82 Billion | CN¥249.77 Million | 0.089x | +24.63% |
| 2021-12-31 | CN¥3.05 Billion | CN¥216.93 Million | 0.071x | -42.48% |
| 2020-12-31 | CN¥3.26 Billion | CN¥403.73 Million | 0.124x | -23.64% |
| 2019-12-31 | CN¥2.73 Billion | CN¥442.17 Million | 0.162x | +91.21% |
| 2018-12-31 | CN¥2.41 Billion | CN¥203.95 Million | 0.085x | +4151.69% |
| 2017-12-31 | CN¥2.09 Billion | CN¥-4.37 Million | -0.002x | +90.26% |
| 2016-12-31 | CN¥2.05 Billion | CN¥-44.13 Million | -0.021x | -156.14% |
| 2015-12-31 | CN¥1.42 Billion | CN¥54.16 Million | 0.038x | +46.00% |
| 2014-12-31 | CN¥685.38 Million | CN¥17.96 Million | 0.026x | -88.20% |
| 2013-12-31 | CN¥305.76 Million | CN¥67.91 Million | 0.222x | -12.08% |
| 2012-12-31 | CN¥242.72 Million | CN¥61.32 Million | 0.253x | -11.23% |
| 2011-12-31 | CN¥188.00 Million | CN¥53.50 Million | 0.285x | +16.59% |
| 2010-12-31 | CN¥144.81 Million | CN¥35.35 Million | 0.244x | +17.85% |
| 2009-12-31 | CN¥123.79 Million | CN¥25.64 Million | 0.207x | +9.18% |
| 2007-12-31 | CN¥77.75 Million | CN¥14.75 Million | 0.190x | -- |